Versigent (NYSE:VGNT) Stock Rating Upgraded by Argus

Versigent (NYSE:VGNTGet Free Report) was upgraded by investment analysts at Argus to a “strong-buy” rating in a research report issued on Tuesday,Zacks.com reports.

A number of other analysts also recently issued reports on the stock. Royal Bank Of Canada raised their price target on shares of Versigent from $34.00 to $41.00 and gave the company a “sector perform” rating in a report on Monday, July 13th. The Goldman Sachs Group initiated coverage on shares of Versigent in a report on Monday. They set a “buy” rating and a $48.00 price objective for the company. Oppenheimer set a $50.00 price objective on shares of Versigent in a research report on Tuesday. Zacks Research raised shares of Versigent from a “hold” rating to a “strong-buy” rating in a research report on Thursday, July 2nd. Finally, Evercore reiterated an “outperform” rating and set a $60.00 target price on shares of Versigent in a research note on Monday, May 18th. Four investment analysts have rated the stock with a Strong Buy rating, eight have given a Buy rating and one has assigned a Hold rating to the company. Based on data from MarketBeat.com, the company presently has an average rating of “Buy” and an average target price of $49.67.

Check Out Our Latest Report on VGNT

Versigent Stock Up 2.8%

NYSE VGNT opened at $41.15 on Tuesday. Versigent has a one year low of $26.34 and a one year high of $50.88. The stock has a 50-day simple moving average of $43.42.

Recommended Stories

Analyst Recommendations for Versigent (NYSE:VGNT)

Receive News & Ratings for Versigent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Versigent and related companies with MarketBeat.com's FREE daily email newsletter.